Why Menarini’s European GLP-1 Deal Matters for Peptide…

Discovery: where manufacturability is decided Licensing tends to surface a discovery-stage reality that gets skimmed over when a molecule is still “only…

How Oral GLP-1 Rewrites the Peptide Development Brief

Why Oral Delivery Reshapes the Development Mandate An orally delivered peptide must survive conditions an injectable never encounters. The gastrointestinal tract presents…

From Mouse Longevity Claims to Human Trials: א…

Structure of the Evidence Between “intriguing mouse finding” and “clinical conclusion” sit measurable attrition points that do not depend on which peptide…